SCHEMBL8764369

SCHEMBL8764369

Nc1ccc(-c2c(C(F)(F)F)nn(-c3ccc(N)cc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.64
PTGS1 P23219 14/20 0.64
CYP2C9 P11712 1/20 0.48
PDPK1 O15530 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8631459 0.95 PTGS2 (0.70) PTGS2PTGS1PDPK1
SCHEMBL8638187 0.94 PTGS2 (0.65) PTGS2PTGS1PDPK1
SCHEMBL8765525 0.90 PTGS2 (0.64) PTGS2PTGS1CYP2C9PDPK1
SCHEMBL8609145 0.90 PTGS2 (0.65) PTGS2PTGS1
SCHEMBL8765053 0.90 PTGS2 (0.64) PTGS2PTGS1CYP2C9
SCHEMBL8765139 0.89 PTGS2 (0.63) PTGS2PTGS1
SCHEMBL8766197 0.89 PTGS2 (0.52) PTGS2PTGS1CYP2C9
SCHEMBL8765415 0.89 PTGS2 (0.67) PTGS2PTGS1CYP2C9PDPK1
SCHEMBL8765119 0.89 PTGS2 (0.66) PTGS2PTGS1CYP2C9
SCHEMBL8765178 0.89 PTGS2 (0.80) PTGS2PTGS1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed